Related Experiment Video
Updated: Jun 22, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Comparison of inflammatory biomarkers between diabetic and non-diabetic patients with unstable angina
Marçal de Oliveira Huoya1, Rafaela Andrade Penalva, Sílber Rodrigues Alves
1Divisão de Cardiologia, Hospital Santa Izabel, Salvador, Brazil. mohuoya@cardiol.br
Insights
Diabetic and non-diabetic patients with unstable angina show similar inflammatory activity, suggesting acute-phase protein increase is independent of metabolic state. This challenges the notion that inflammation drives worse outcomes in diabetic patients with this condition.
Area of Science:
- Cardiology
- Endocrinology
- Immunology
Background:
- Limited research exists on inflammatory differences between diabetic and non-diabetic individuals with acute coronary syndrome.
- No prior studies have specifically compared inflammation in unstable angina (UA) patients with and without diabetes.
Purpose of the Study:
- To compare serum C-reactive protein (CRP) and interleukin-6 (IL-6) levels in diabetic versus non-diabetic UA patients.
- To investigate if inflammatory differences explain poorer prognosis in diabetic UA patients.
- To assess correlations between inflammatory markers, metabolic profiles, and in-hospital outcomes in diabetic UA patients.
Main Methods:
- A prospective cohort study involving 90 consecutive UA patients.
- Patients were categorized into diabetic and non-diabetic groups.
- Serum CRP, IL-6, leukocyte count, and metabolic profiles were measured upon hospital admission.
Main Results:
- No significant differences in median CRP or IL-6 levels were observed between diabetic and non-diabetic UA patients.
- Positive correlations were found between CRP and total cholesterol, LDL-cholesterol, and leukocyte count in both groups.
- No associations were identified between inflammatory markers and in-hospital outcomes (death, myocardial infarction, heart failure, length of stay).
Conclusions:
- Diabetic and non-diabetic patients with unstable angina exhibit comparable inflammatory activity.
- The increase in acute-phase proteins during UA appears to be independent of the patient's metabolic state (diabetic or non-diabetic).
- Inflammatory activity differences do not seem to be the primary driver of worse prognosis in diabetic UA patients.
Background:
Studies comparing inflammatory activity between diabetic and non-diabetic individuals with acute coronary syndrome are scarce, and none including only patients with unstable angina (UA) has been published to date.
Objective:
We compared serum C-reactive protein (CRP), and interleukin-6(IL-6) between diabetic and non-diabetic patients with unstable angina (UA) to determine if difference in inflammatory activity is responsible for a worse prognosis in diabetic patients. We also evaluated the correlation between inflammatory markers and the metabolic profile in diabetic patients and the correlation between inflammatory response and in-hospital outcomes: death, acute myocardial infarction, congestive heart failure, and length of stay in hospital.
Methods:
A prospective cohort study of 90 consecutive patients admitted to a chest pain unit with UA and divided into two groups, diabetic and non-diabetic. Serum CRP, IL-6, metabolic profile and leukocyte count were measured at hospital arrival.
Results:
Forty-two patients (47%) were diabetic (age 62+/-9) vs. 48 (53%) non-diabetic (age 63+/-12). No differences between median C-reactive protein (1.78 vs. 2.23 mg/l,p=0.74) and interleukin-6 (0 vs. 0 pg/ml,p=0.31) were found between the two groups. There was a positive correlation between CRP and total cholesterol (rs = 0.21,p = 0.05), CRP and LDL-cholesterol (rs=0.22,p=0.04) and between CRP and leukocyte count (rs = 0.32, p = 0.02) in both groups. No associations were found between inflammatory markers and in-hospital outcomes.
Conclusion:
We found no difference in inflammatory activity between diabetic and non-diabetic patients with UA, suggesting that this clinical condition may result in balanced inflammatory activity between the two groups and increase acute-phase proteins independently of metabolic state.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Angina II: Classification
Angina III: Clinical Manifestations and Assessment
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations